|
Legaz I, Bolarin JM, Campillo JA, Moya RM, Luna A, Osuna E, Minguela A, Sanchez-Bueno F, Alvarez MR, Muro M. Pretransplant ascites and encephalopathy and their influence on survival and liver graft rejection in alcoholic cirrhosis disease. Arch Med Sci. 2019 Jun 18;17(3):682-693. doi: 10.5114/aoms.2018.80651. eCollection 2021. PubMed PMID: 34025838; PubMed Central PMCID: PMC8130464.
AÑO: 2021; IF: 3.707
|
34025838
|
Vasco-Mogorron MA, Campillo JA, Periago A, Cabanas V, Berenguer M, Garcia-Garay MC, Gimeno L, Soto-Ramirez MF, Martinez-Hernandez MD, Muro M, Minguela A. Blood-based risk stratification for pre-malignant and symptomatic plasma cell neoplasms to improve patient management. Am J Cancer Res. 2021 Jun 15;11(6):2736-2753. eCollection 2021. PubMed PMID: 34249425; PubMed Central PMCID: PMC8263680.
AÑO: 2021; IF: 5.942
|
|
Legaz I, Bolarin JM, Navarro E, Campillo JA, Moya R, Perez-Carceles MD, Luna A, Osuna E, Miras M, Muro M, Minguela A, Alvarez Lopez R. KIR2DL2/S2 and KIR2DS5 in alcoholic cirrhotic patients undergoing liver transplantation. Arch Med Sci. 2019 Apr 9;17(3):764-774. doi: 10.5114/aoms.2019.84410. eCollection 2021. PubMed PMID: 34025847; PubMed Central PMCID: PMC8130473.
AÑO: 2021; IF: 3.707
|
|
Muro M, Llorente S, Gónzalez-Soriano MJ, Minguela A, Gimeno L, Alvarez-López MR. Pre-formed donor-specific alloantibodies (DSA) detected only by luminex technology using HLA-coated microspheres and causing acute humoral rejection and kidney graft dysfunction. Clin Transpl. 2006:379-83. PubMed PMID: 18365392.
AÑO: 2006
|
|
Alcaraz MJ, Alcaraz A, Teruel-Montoya R, Campillo JA, de la Torre A, Munoz A, Tomas C, Puche G, Baguena C, Cano A, Minguela A, Bernal E. Subclinical atherosclerosis and immune activation in young HIV-infected patients with telomere shortening. Aging (Albany NY). 2021 Jul 26;13(14):18094-18105. doi: 10.18632/aging.203350. Epub 2021 Jul 26. PubMed PMID: 34310343; PubMed Central PMCID: PMC8351718.
AÑO: 2021; IF: 5.955
|